OtherBasic Science Investigations
In Vivo Formation of γ-H2AX and 53BP1 DNA Repair Foci in Blood Cells After Radioiodine Therapy of Differentiated Thyroid Cancer
Michael Lassmann, Heribert Hänscheid, Daniela Gassen, Johannes Biko, Viktor Meineke, Christoph Reiners and Harry Scherthan
Journal of Nuclear Medicine July 2010, DOI: https://doi.org/10.2967/jnumed.109.071357
Michael Lassmann
Heribert Hänscheid
Daniela Gassen
Johannes Biko
Viktor Meineke
Christoph Reiners


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 6
June 1, 2025
In Vivo Formation of γ-H2AX and 53BP1 DNA Repair Foci in Blood Cells After Radioiodine Therapy of Differentiated Thyroid Cancer
Michael Lassmann, Heribert Hänscheid, Daniela Gassen, Johannes Biko, Viktor Meineke, Christoph Reiners, Harry Scherthan
Journal of Nuclear Medicine Jul 2010, DOI: 10.2967/jnumed.109.071357
In Vivo Formation of γ-H2AX and 53BP1 DNA Repair Foci in Blood Cells After Radioiodine Therapy of Differentiated Thyroid Cancer
Michael Lassmann, Heribert Hänscheid, Daniela Gassen, Johannes Biko, Viktor Meineke, Christoph Reiners, Harry Scherthan
Journal of Nuclear Medicine Jul 2010, DOI: 10.2967/jnumed.109.071357
Jump to section
Related Articles
- No related articles found.
Cited By...
- Machine Learning Classification of 53BP1 Foci
- DNA damage response in peripheral mouse blood leukocytes in vivo after variable, low-dose rate exposure
- The Relevance of Dosimetry in Precision Medicine
- DNA Damage in Peripheral Blood Lymphocytes of Thyroid Cancer Patients After Radioiodine Therapy
- 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma
- Analysis of 177Lu-DOTA-Octreotate Therapy-Induced DNA Damage in Peripheral Blood Lymphocytes of Patients with Neuroendocrine Tumors